Economic assessment in the management of non-Hodgkin’s lymphoma

Author： van Agthoven Michel   Uyl-de Groot Carin A   Sonneveld Pieter   Hagenbeek Anton  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.12, 2004-12, pp. : 2529-2548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment advances in non-Hodgkin’s lymphoma

By Tan B.R.   Bartlett N.L.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 451-465

Informa Healthcare

Access to resources Recommend Favorite

The role of pixantrone in the treatment of non-Hodgkin’s lymphoma

By Borchmann Peter  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1055-1061

Informa Healthcare

Access to resources Recommend Favorite

Gallium nitrate for the treatment of non-Hodgkin’s lymphoma

By Chitambar Christopher R  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 531-541

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin’s Lymphoma

By Limat Samuel   Demesmay Karine  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 719-729

Adis International

Access to resources Recommend Favorite

Novel treatment strategies for aggressive non-Hodgkin’s lymphoma

By Fayad Luis   Younes Anas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 733-748

Informa Healthcare

Access to resources Recommend Favorite